Fusarium head blight (FHB), caused mainly by Fusarium graminearum, is one of the most important diseases of barley and wheat in Brazil. The disease causes yield losses and contaminates grain with mycotoxins produced by the fungus, mainly deoxynivalenol (DON) and zearalenone (ZEA). The objective of this study was to summarize the results of 16,487 analyses of DON and ZEA in barley and wheat commercial grain produced in Brazil from 2008 to 2015 using liquid chromatography tandem-mass spectrometry. For barley, DON and ZEA were detected in 67% and 41% of the samples, respectively, but 19% and 18% were above the maximum tolerated limits (MTL = 1250 μg/kg for DON and 100 μg/ kg for ZEA). For wheat, DON and ZEA were detected in 73 and 38% with 30% and 9% of the samples above the MTL (1250 μg/kg for DON and 200 μg/kg for ZEA). The overall mean concentration of DON was 737 μg/kg in barley and 660 μg/kg in wheat. The mean yearly DON levels varied less in barley (446 μg/kg to 1114 μg/kg) compared to wheat (346 μg/ kg to 1274 μg/kg). For the latter, a high peak of DON was found in 2014 when 58% of the samples were above the MTL and the toxin levels averaged 1274 μg/kg across all samples. The mean yearly concentration of ZEA was 138 and 111 μg/ kg for barley and wheat, respectively, with the highest prevalence and concentration reported in 2008 and 2009, for both crops. To our knowledge, this is the most comprehensive summary of DON and ZEA contamination in barley and wheat in Brazil for almost a decade of monitoring. Continuous assessment and close inspection of highly contaminated batches are essential to ensure food safety and mitigate the risk that these mycotoxins can cause to human and animal health.
The inclusion of anti-mycotoxin additives (AMA) in the diet of production animals has been widely used to avoid mycotoxin exposure. In order to confirm the efficacy of such products in vivo, measurement of mycotoxins and/or their metabolites in biological fluids is preconized. This study aimed at determining the serological biomarkers of zearalenone (ZEN), α-zearalenol, β-zearalenol, α-zearalanol, β-zearalanol (β-ZAL) and zearalanone, to evaluate the efficacy of an AMA in beef heifers. The trial lasted 37 days: 11 days of adaptation, 21 days of actual experiment, and 5 days of regression. Twenty-four heifers were randomly assigned to receive one of the following treatments (n=6/group): (T1) basal diet (control); (T2) basal diet + 5 mg/kg of ZEN; (T3) basal diet + 5 mg/kg of ZEN + 2.5 kg/t of AMA; and (T4) basal diet + 5 mg/kg of ZEN + 5.0 kg/t of AMA. Blood sampling was performed on different days after the diet was given. The samples were centrifuged to obtain the blood serum, and then analysed by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). β-ZAL was detected above the limit of quantification both in the unconjugated (>0.60 ng/ml) and conjugated (>0.90 ng/ml) forms. The remaining metabolites presented concentrations under the limit of detection. In the efficacy evaluation of the AMA, there was no significant difference (P>0.05) between the treatments with and without additive at the tested levels of inclusion. Thus, β-ZAL may be employed as a biomarker of ZEN exposure via diet to evaluate the efficacy of an AMA through serological parameters. The technique applied in this study proved to be an adequate alternative for in vivo confirmation of the efficacy of products in adsorbing the toxin.
Este documento possui uma licença Creative Commons. Atribuição: esta obra não pode ser usada para fins comerciais; ao citar direta ou indiretamente este conteúdo, deve-se dar crédito ao autor original; e a obra derivada desta deve ser distribuída sob uma licença idêntica a esta. UMA A NUTRITION EDUCATION EXPERIENCE IN THERAPEUTIC SETTING OF CHEMICAL DEPENDENCY AbstractThe addiction is a public health problem for which many therapeutic approaches are directed.This paper presents an experience in humanized nutrition education, aiming to contribute to the quality of life of chemical dependents and to give students a chance for practicing the professional profile proposed by the pedagogical project that guides their educational training.The experience was positively evaluated by all involved.
In vitro tests are performed to evaluate the efficacy of antimycotoxins additives (AMAs); nevertheless, such assays show a low correlation with in vivo trials, which are also required to determine AMAs’ efficacy. In search of an alternative method, the current study investigated the use of an ex vivo technique. Six AMAs (AMA1 to AMA6) had their ability to reduce intestinal absorption of aflatoxin B1 (AFB1) evaluated. Jejunal explants were obtained from broilers and subjected to two treatments per AMA in Ussing chambers: T1 (control) - 2.8 mg/L AFB1, and T2 - 2.8 mg/L AFB1 + 0.5% AMA. AMAs were also tested in vitro to assess adsorption of AFB1 in artificial intestinal fluid. In the ex vivo studies, AMA1 to AMA6 decreased intestinal absorption of AFB1 by 67.11%, 73.82%, 80.70%, 85.86%, 86.28% and 82.32%, respectively. As for the in vitro results, AMA1 to AMA6 presented an adsorption of 99.72%, 99.37%, 99.67%, 99.53%, 99.04% and 99.15%, respectively. The evaluated ex vivo model proved useful in the assessment of AMAs. No correlation was reported between ex vivo and in vitro findings. Further studies are needed to elucidate the correlation between ex vivo and in vivo results seeking to reduce animal testing.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.